
|Podcasts|February 23, 2022
The changing landscape of gene therapy and standardized endpoints
Author(s)David Hutton
In this episode of EyePod, Ora Clinical’s Keith Lane offers a brief overview of the current state of ophthalmology and its standardized endpoints. He also discusses some of the challenges that gene therapy has faced, particularly in relation to ophthalmology. He also offers his outlook for the future of gene therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Rayner’s RayOne EMV Toric intraocular lens
2
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
3
NeuroOp Guru: When proptosis isn’t thyroid eye disease
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5